Venture Life Group plc (VLG.L)
LSE · GBp · Consumer Defensive · Household & Personal Products
£67.00 (+0.00%) as of
Key statistics
- Market cap
- 79.55M
- Forward P/E
- 8.00
- EPS (TTM)
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- 53.00 – 72.00
- Beta
- 0.17
- Revenue (TTM)
- 35.27M
- Profit margin
- 6.83%
- Analyst target
- £150.00
- Volume
- 19.67k
About Venture Life Group plc
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. It also provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; and Glucogel for the treatment of hypoglycaemia. In addition, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; and Baby Earol, an ear spray for babies under the Earol and EarolSwim brands. Further, it provides oncology support products, such as Pomi-T for the management of prostate-specific antigen levels in prostate cancer; and Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis. The company operates in Germany, the Netherlands, Norway, France, Sweden, Denmark, Lithuania, rest of Europe, the United States, Canada, Brazil, Ireland, and internationally. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Headquarters
- Bracknell, United Kingdom
- Employees
- 63
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.